PharmaLogic Holdings Corp News and Resources

Life Molecular Imaging (LMI) and PharmaLogic Holdings Corp. have announced a strategic partnership and licensing agreement to distribute Neuraceq® from PharmaLogic’s radiopharmaceutical manufacturing site near Denver, Colorado. The collaboration aims to enhance the availability of this FDA-approved imaging agent used

Nusano Inc., medical radioisotope producer, has entered into a supply agreement with PharmaLogic Holdings Corp., a radiopharmaceutical CDMO. This partnership aims to enhance the supply chain for critical radioisotopes used in emerging cancer therapies. The agreement ensures a more reliable

PharmaLogic has announced the opening of its new radiopharmaceutical production and research facility in Cincinnati, Ohio. The facility was officially opened on April 22, 2024. The new production and laboratory space is equipped to allow PharmaLogic to increase current production